ArticleThe breast journal2025

Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.

Atif Ali Hashmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.